HADH may be the target molecule of early vascular endothelial impairment in T2DM

BACKGROUND: Type 2 diabetes mellitus (T2DM) will significantly increase the risk of atherosclerosis (AS). Vascular endothelial cell dysfunction (VECD) is the foundation of AS. Early identification and intervention of VECD caused by T2DM can help us effectively delay or even suppress the occurrence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Haowen, Wang, Ruxin, Wei, Jinjing, Wang, Ying, Wang, Lihong, Zhang, Xiaofang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399638/
https://www.ncbi.nlm.nih.gov/pubmed/36035955
http://dx.doi.org/10.3389/fcvm.2022.963916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399638/
https://www.ncbi.nlm.nih.gov/pubmed/36035955
http://dx.doi.org/10.3389/fcvm.2022.963916

Ejemplares similares